APA (7th ed.) Citation

Liu, D., Qin, Z., Yi, B., Xie, H., Liang, Y., Zhu, L., . . . Zhang, H. (2024). Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer. Cancer Cell International, 24(1), 1. https://doi.org/10.1186/s12935-024-03477-0

Chicago Style (17th ed.) Citation

Liu, Dongze, Zheng Qin, Bocun Yi, Hongbo Xie, Yunan Liang, Liang Zhu, Kuo Yang, Yong Xu, and Hongtuan Zhang. "Telomerase Related Molecular Subtype and Risk Model Reveal Immune Activity and Evaluate Prognosis and Immunotherapy Response in Prostate Cancer." Cancer Cell International 24, no. 1 (2024): 1. https://doi.org/10.1186/s12935-024-03477-0.

MLA (9th ed.) Citation

Liu, Dongze, et al. "Telomerase Related Molecular Subtype and Risk Model Reveal Immune Activity and Evaluate Prognosis and Immunotherapy Response in Prostate Cancer." Cancer Cell International, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12935-024-03477-0.